Format

Send to

Choose Destination
Drug Discov Today. 2003 Oct 15;8(20):934-43.

Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.

Author information

1
Galenica Pharmaceuticals, Inc., 2800 Milan Court, Suite 118, Birmingham, Alabama 35211, USA. marciani.gpi@att.net

Abstract

Inactivated vaccines require adjuvants to stimulate an immune response. The choice of adjuvant or immune enhancer determines whether the immune response is effective, ineffective or damaging. Accordingly, there is a need for new adjuvants that stimulate the appropriate immunity, for example, T cell immunity for intracellular pathogens and cancer vaccines. In several adjuvants, the identification of chemical groups that interact with specific cell toll-like receptors (innate immunity) or receptors for co-stimulatory ligands (adaptive immunity), has enabled the establishment of structure-function relationships that are useful in the design of new adjuvants. Because of the crucial immunomodulating role of adjuvants, sub-unit vaccine development will remain dependent on new adjuvants.

PMID:
14554157
DOI:
10.1016/s1359-6446(03)02864-2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center